Keay Nakae
Stock Analyst at Chardan Capital
(3.13)
# 1,160
Out of 4,862 analysts
232
Total ratings
31.86%
Success rate
4.86%
Average return
Main Sectors:
Stocks Rated by Keay Nakae
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SLN Silence Therapeutics | Maintains: Buy | $35 | $5.40 | +548.15% | 12 | Jun 13, 2025 | |
| RNA Avidity Biosciences | Maintains: Buy | $65 → $75 | $31.33 | +139.39% | 17 | Jun 9, 2025 | |
| SABS SAB Biotherapeutics | Maintains: Buy | $20 | $1.60 | +1,150.00% | 15 | May 15, 2025 | |
| OBIO Orchestra BioMed Holdings | Maintains: Buy | $20 | $3.09 | +547.25% | 10 | May 13, 2025 | |
| KRRO Korro Bio | Maintains: Buy | $25 | $13.54 | +84.64% | 2 | May 13, 2025 | |
| COYA Coya Therapeutics | Maintains: Buy | $14 | $5.58 | +150.90% | 18 | May 13, 2025 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $60 | $15.74 | +281.19% | 19 | May 13, 2025 | |
| DYN Dyne Therapeutics | Maintains: Buy | $50 | $14.40 | +247.22% | 11 | May 9, 2025 | |
| MCRB Seres Therapeutics | Downgrades: Neutral | $1.25 → $6 | $7.50 | -20.00% | 10 | May 8, 2025 | |
| IBIO iBio, Inc. | Maintains: Buy | $5 | $0.93 | +438.74% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $325 | $307.99 | +5.52% | 13 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 | $1.15 | +1,639.13% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 | $1.73 | +246.82% | 7 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 | $3.53 | +41.64% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $2.5 | $2.48 | +0.81% | 6 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.88 | +112.77% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $8 | $0.89 | +799.58% | 10 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.25 | - | 5 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $8 → $6 | $11.78 | -49.07% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $20 | $0.41 | +4,789.98% | 4 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $65 → $55 | $6.25 | +780.00% | 10 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.25 → $10 | $8.77 | +14.03% | 5 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $100 → $88 | $12.09 | +624.04% | 2 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $0.7 → $13 | $1.13 | +1,050.44% | 3 | Feb 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $155 → $40 | $2.68 | +1,395.33% | 2 | Jun 30, 2020 |
Silence Therapeutics
Jun 13, 2025
Maintains: Buy
Price Target: $35
Current: $5.40
Upside: +548.15%
Avidity Biosciences
Jun 9, 2025
Maintains: Buy
Price Target: $65 → $75
Current: $31.33
Upside: +139.39%
SAB Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $20
Current: $1.60
Upside: +1,150.00%
Orchestra BioMed Holdings
May 13, 2025
Maintains: Buy
Price Target: $20
Current: $3.09
Upside: +547.25%
Korro Bio
May 13, 2025
Maintains: Buy
Price Target: $25
Current: $13.54
Upside: +84.64%
Coya Therapeutics
May 13, 2025
Maintains: Buy
Price Target: $14
Current: $5.58
Upside: +150.90%
Arrowhead Pharmaceuticals
May 13, 2025
Maintains: Buy
Price Target: $60
Current: $15.74
Upside: +281.19%
Dyne Therapeutics
May 9, 2025
Maintains: Buy
Price Target: $50
Current: $14.40
Upside: +247.22%
Seres Therapeutics
May 8, 2025
Downgrades: Neutral
Price Target: $1.25 → $6
Current: $7.50
Upside: -20.00%
iBio, Inc.
May 6, 2025
Maintains: Buy
Price Target: $5
Current: $0.93
Upside: +438.74%
May 2, 2025
Maintains: Buy
Price Target: $300 → $325
Current: $307.99
Upside: +5.52%
Apr 7, 2025
Maintains: Buy
Price Target: $20
Current: $1.15
Upside: +1,639.13%
Mar 28, 2025
Maintains: Buy
Price Target: $6
Current: $1.73
Upside: +246.82%
Mar 28, 2025
Maintains: Buy
Price Target: $5
Current: $3.53
Upside: +41.64%
Mar 27, 2025
Maintains: Neutral
Price Target: $2.5
Current: $2.48
Upside: +0.81%
Mar 14, 2025
Maintains: Buy
Price Target: $4
Current: $1.88
Upside: +112.77%
Nov 13, 2024
Maintains: Buy
Price Target: $10 → $8
Current: $0.89
Upside: +799.58%
Feb 9, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.25
Upside: -
Aug 4, 2023
Maintains: Sell
Price Target: $8 → $6
Current: $11.78
Upside: -49.07%
Nov 10, 2022
Maintains: Buy
Price Target: $60 → $20
Current: $0.41
Upside: +4,789.98%
Nov 9, 2022
Maintains: Buy
Price Target: $65 → $55
Current: $6.25
Upside: +780.00%
Aug 16, 2022
Maintains: Neutral
Price Target: $1.25 → $10
Current: $8.77
Upside: +14.03%
Sep 20, 2021
Upgrades: Neutral
Price Target: $100 → $88
Current: $12.09
Upside: +624.04%
Feb 9, 2021
Downgrades: Neutral
Price Target: $0.7 → $13
Current: $1.13
Upside: +1,050.44%
Jun 30, 2020
Downgrades: Neutral
Price Target: $155 → $40
Current: $2.68
Upside: +1,395.33%